Quanterix Corp (QTRX) Financial Statements (2026 and earlier)

Company Profile

Business Address 900 MIDDLESEX TURNPIKE
BILLERICA, MA 01821
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments289,122321,324338,740396,465181,584109,155
Cash and cash equivalent56,709174,422338,740396,465181,584109,155
Short-term investments232,413146,902    
Restricted cash and investments     1,000 
Receivables32,14125,41419,10623,98617,35611,092
Inventory, net of allowances, customer advances and progress billings32,77526,12316,78622,19014,85610,463
Inventory32,77526,12316,78622,19014,85610,463
Other undisclosed current assets9,5569,2346,7716,3144,8091,951
Total current assets:363,594382,095381,403448,955219,605132,661
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization      
Operating lease, right-of-use asset16,33918,25121,22311,49111,995 
Property, plant and equipment17,15017,92620,16217,96013,91212,047
Intangible assets, net (including goodwill)4,0316,0347,51620,16624,17623,660
Goodwill   9,63210,4609,353
Intangible assets, net (excluding goodwill)4,0316,0347,51610,53413,71614,307
Restricted cash and investments2,6102,6042,5972,5771,0001,026
Other noncurrent assets2,8091,6571,298378357557
Total noncurrent assets:42,93946,47252,79652,57251,44037,290
TOTAL ASSETS:406,533428,567434,199501,527271,045169,951
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26,84923,32519,24128,94722,42114,845
Employee-related liabilities13,25210,7776,570
Accounts payable6,9535,0483,8369,2096,7995,777
Accrued liabilities19,89618,27715,4056,4864,8452,498
Deferred revenue8,8279,4688,6446,3615,4214,697
Debt    8,90775
Business combination, contingent consideration, liability      
Other liabilities   3862413,054216
Due to related parties 42  
Other undisclosed current liabilities6,3316,1892,6871,386  
Total current liabilities:42,00738,98230,95836,97739,80319,833
Noncurrent Liabilities
Long-term debt and lease obligation   20,46421,8917,587
Long-term debt, excluding current maturities      7,587
Finance lease, liability      
Liabilities, other than long-term debt34,48839,62744,3013,1343,22613,873
Deferred revenue1,0731,2271,4151,099577466
Deferred income tax liabilities    2,035  
Other liabilities8001,1771,469 2,64913,407
Operating lease, liability32,61537,22341,41720,46421,891 
Business combination, contingent consideration, liability      
Total noncurrent liabilities:34,48839,62744,30123,59825,11721,460
Total liabilities:76,49578,60975,25960,57564,92041,293
Equity
Equity, attributable to parent330,038349,958358,940440,952206,125128,658
Common stock393837373228
Additional paid in capital803,160783,142763,688745,936451,433345,027
Accumulated other comprehensive income (loss)(3,080)(1,672)(2,623)4412,434(153)
Accumulated deficit(470,081)(431,550)(402,162)(305,462)(247,774)(216,244)
Total equity:330,038349,958358,940440,952206,125128,658
TOTAL LIABILITIES AND EQUITY:406,533428,567434,199501,527271,045169,951

Income Statement (P&L) ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues137,421122,368105,522110,55686,37756,734
Cost of revenue(54,317)(48,144)(58,716)(48,828)(38,195)(29,898)
Gross profit:83,10474,22446,80661,72848,18226,836
Operating expenses(135,720)(120,215)(148,510)(120,314)(79,766)(68,436)
Operating loss:(52,616)(45,991)(101,704)(58,586)(31,584)(41,600)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(136)2,517(62)1,265(49)(10)
Loss from continuing operations before equity method investments, income taxes:(52,752)(43,474)(101,766)(57,321)(31,633)(41,610)
Other undisclosed income (loss) from continuing operations before income taxes14,65515,8395,131(403)(273)627
Loss from continuing operations before income taxes:(38,097)(27,635)(96,635)(57,724)(31,906)(40,983)
Income tax expense (benefit)(434)(719)(65)36376187
Loss from continuing operations:(38,531)(28,354)(96,700)(57,688)(31,530)(40,796)
Loss before gain (loss) on sale of properties:(57,688)(31,530)(40,796)
Net loss available to common stockholders, diluted:(38,531)(28,354)(96,700)(57,688)(31,530)(40,796)

Comprehensive Income ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(38,531)(28,354)(96,700)(57,688)(31,530)(40,796)
Comprehensive loss:(38,531)(28,354)(96,700)(57,688)(31,530)(40,796)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,408)866(3,064)(1,993)2,587(153)
Comprehensive loss, net of tax, attributable to parent:(39,939)(27,488)(99,764)(59,681)(28,943)(40,949)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: